Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study

Cetuximab improves efficacy when added to chemotherapy for metastatic colorectal cancer (mCRC). Effective management of skin reactions from cetuximab improves quality of life (QoL), and treatment compliance in clinical trials. No data are available from real‐world settings. The ObservEr observationa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Pinto, Carmine, Di Fabio, Francesca, Rosati, Gerardo, Lolli, Ivan R., Ruggeri, Enzo M., Ciuffreda, Libero, Ferrari, Daris, Lo Re, Giovanni, Rosti, Giovanni, Tralongo, Paolo, Ferrara, Raimondo, Alabiso, Oscar, Chiara, Silvana, Ianniello, Giovanni P., Frassoldati, Antonio, Bilancia, Domenico, Campanella, Giovanna A., Signorelli, Carlo, Racca, Patrizia, Benincasa, Elena, Stroppolo, Maria Elena, Di Costanzo, Francesco
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2016
Schlagworte:
Cancer Prevention
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119983/
https://ncbi.nlm.nih.gov/pubmed/27748041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.888
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge